|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Pyrosequencing using the single-nucleotide polymorphism protocol for rapid determination of TEM-and SHV-type extended-spectrum beta-lactamases in clinical isolates and identification of the novel beta-lactamase genes blaSHV-48,blaSHV-105,and blaTEM-155显示文摘 | Jones CH Ruzin A Tuckman M | | 0，，03： | 1 |
| 2 | Characterization and se- quence analysis of extended-spectrum-β-lactamase-encoding genes from Escherichia coli, KlebsieUa pneumoniae, and Proteus mlrabilis isolates collected during tigecycline phase 3 clinical trials显示文摘 | Jones CH Tuckman M Keeney D | 2009 | Antimicrab Agents Chemother2009，53，2： | 1 |
| 3 | Characterization and sequence analysis of extended-spectrum β-lactamase-encoding genes from Escherichia coli,Klebsiella pneumoniae,and Proteus mirabilis isolates collected during tigecycline phase 3 clinical trials显示文摘 | Jones CH Tuckman M Keeney D | | 0，，02： | 1 |
| 4 | Markers of endometrial function in women with unexplained recurrent pregnancy loss:a comparison between morphologically normal and retarded endometrium显示文摘 | Tuckman E Laird S M Steward R | | 0，，01： | 1 |
| 5 | In vitro activity of tigecy- cline against patient isolates collected during phase 3 clinical trials for hospital acquired pneumonia显示文摘 | Petersen PJ Tuckman M Jones H | 2010 | Infectious Disease Reports2010，2，1： | 1 |
| 6 | Stages of Small-group Development Revisited 显示文摘 | Tuckman B W Jnsen M A C | 1977 | Group & Organization Management1977，2，4： | 1 |
| 7 | Carbapenem-resistant Escherichia coli harboring Klebsiella pneumoniae carbapenemase beta-lactamases associated with long-term care facilities显示文摘 | Urban C Bradford PA Tuckman M | 2008 | Clin Infect Dis2008，46，11： | 1 |
| 8 | Characteri- zation and sequence analysis of extended-spectrum- beta-lactamase-encoding genes from Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates collected during tigecycline phase 3 clinical trials 显示文摘 | Jones CH Tuckman M Keeney D | 2009 | Antimicrob Agents Chemother2009，53，2： | 1 |
| 9 | Identification and sequence of a tettetracycline resistance determinant homologue in clinical isolates of Escherichia coli显示文摘 | Jones C H Tuckman M Murphy E | 2006 | Journal of Bacteriology2006，188，20： | 1 |
| 10 | Identification and sequence of a tet (M) tetracycline resistance determinant homo logue in clinical isolates of Escherichia coli显示文摘 | JONES C H TUCKMAN M MURPHY E | | 0，，20： | 1 |
| 11 | Stages of small-group development revisited 显示文摘 | TUCKMAN B W JENSEN M A C | 1997 | Group & Organization Management1997，2，4： | 1 |
| 12 | Characterization and sequence analysis of extended-spectrum-t beta l-lactamase-encoding genes from Escherichia coli, Klebsiella pneumoniae, and Proteus Mirabills isolates collected during tigecycline phase 3 clinical trials显示文摘 | Jones CH Tuckman M Keeney D | 2009 | Antimicrob Agents Chemother2009，53，2： | 1 |
| 13 | In vitro activi- ty of tigecycline against isolates from patients enrolled in phase 3 clinical trials for complieated skin and skin structure infections and complicated intra-abdominal infections 显示文摘 | Bradford PA Petersen PJ Tuckman M | 2005 | Clin Infect Dis2005，41，5： | 1 |
| 14 | In vitro activity of tigecycline against patient isolates collected during phase 3 clinical trials far hospital acquired pneumonia 显示文摘 | PETERSEN P J TUCKMAN M JONES C H | 2010 | Infect Dis Rep2010，2，1： | 1 |
| 15 | In vitro activity of tigecy cline against patient isolates collected during phase 3 clinical trials for hospital acquired pneumonia 显示文摘 | Petersen PJ Tuckman M Jones H | 2010 | Infectious Disease Reports2010，2，1： | 1 |
| 16 | Carbapenem-resistant Esche- richia coli harboring Klebsiella pneumoniae carbapenemase beta-lactama- ses associated with long-term care facilities显示文摘 | Urban C Bradford PA Tuckman M | 2008 | Clin Infect Dis2008，46，11： | 1 |
| 17 | Stages of small-group development revisited 显示文摘 | TUCKMAN B W JENSEN M C | 1977 | Group and Organization Studies1977，4，2： | 1 |
| 18 | Characterization and sequence analysis of extended-spectrum-{ beta}-lactamase-encoding genes from Eschenchia coli, KIebsiella pneumoniae, and Proteus mirabilis isolates collected during tigecycline phase 3 clinical trials显示文摘 | Jones CH Tuckman M Keeney D | 2009 | Antimicrob Agents Chemother2009，53，2： | 1 |
| 19 | Introduction of foreign DNA intomycobacteria using a shuttle plasmid显示文摘 | Jacobs WR Jr Tuckman M Bloom BR | 1987 | Nature1987，327，： | 1 |
| 20 | Carbapenem-resistant Escherichia coli harboring Klebsiella pneumoniae carbapenemase beta-lactamases associated with long-term care facilities显示文摘 | Urban C Bradford PA Tuckman M | 2008 | Clin Infect Dis2008，46，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员